Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Oral delivery of semaglutide and tirzepatide using milk-derived small extracellular vesicles
When a Lower or Higher Dose Makes Sense This flexible approach is what makes it work
GLP-1 products have driven outsized market value growth: Since the launch of their first GLP-1 products, Novo Nordisk and Eli Lilly have experienced a combined $697 billion increase in market capitalization or total company value, which is 10 times greater than the $71 billion in U.S
Originally developed for the treatment of type 2 diabetes under the brand name Mounjaro, Tirzepatide has since received FDA approval for chronic weight management under the brand name Zepbound making it one of the most powerful medically supervised weight loss tools available today
